chickenpox vaccine

Summary

Summary: A live, attenuated varicella virus vaccine used for immunization against chickenpox. It is recommended for children between the ages of 12 months and 13 years.

Top Publications

  1. doi Laboratory diagnosis and characteristics of breakthrough varicella in children
    Sheila Weinmann
    Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon 97227, USA
    J Infect Dis 197:S132-8. 2008
  2. ncbi Parental attitudes toward varicella vaccination. The Puget Sound Pediatric Research Network
    J A Taylor
    Department of Pediatrics, University of Washington School of Medicine, Seattle 98103 8652, USA
    Arch Pediatr Adolesc Med 154:302-6. 2000
  3. ncbi The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination
    Hester de Melker
    Centre for Infectious Disease Epidemiology, National Institute of Public Health and the Environment, P O Box 1, 3720 BA Bilthoven, The Netherlands
    Vaccine 24:3946-52. 2006
  4. ncbi The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody
    Jay M Lieberman
    Miller Children s Hospital, UCLA Center for Vaccine Research, Long Beach, CA 90806, USA
    Pediatr Infect Dis J 25:615-22. 2006
  5. doi The burden of varicella complications before the introduction of routine varicella vaccination in Germany
    Johannes G Liese
    Dr von Hauner Children s Hospital, Ludwig Maximilians University, Munich, Germany
    Pediatr Infect Dis J 27:119-24. 2008
  6. pmc Attitudes and practices regarding varicella vaccination among physicians in Minnesota: implications for public health and provider education
    K R Ehresmann
    Acute Disease Epidemiology Section, Minnesota Department of Health, Minneapolis 55414, USA
    Am J Public Health 90:1917-20. 2000
  7. ncbi Aging, immunity, and the varicella-zoster virus
    Ann Arvin
    Stanford University School of Medicine, Stanford, Calif, USA
    N Engl J Med 352:2266-7. 2005
  8. ncbi Varicella vaccines and measles, mumps, rubella, and varicella vaccine
    Lucia Ferro Bricks
    Departamento de Pediatria, Faculdade de Medicina da Universidade de São Paulo USP, Sao Paulo, SP, Brazil
    J Pediatr (Rio J) 82:S101-8. 2006
  9. ncbi The effect of vaccination on the epidemiology of varicella zoster virus
    W J Edmunds
    Immunisation Division, Colindale, London NW9 5EQ, UK
    J Infect 44:211-9. 2002
  10. ncbi Instituting a routine varicella vaccination program in Canada: an economic evaluation
    Denis Getsios
    Caro Research, Montreal, Canada
    Pediatr Infect Dis J 21:542-7. 2002

Research Grants

  1. VARICELLA ZOSTER VIRUS
    Anne Gershon; Fiscal Year: 2002
  2. BEHAVIORAL INTERVENTION FOR HERPES ZOSTER RISK IN AGING
    Michael Irwin; Fiscal Year: 2003
  3. Molecular Epidemiology of Fatal Prostate Cancer
    Sheila Weinmann; Fiscal Year: 2006
  4. PEDIATRICS AIDS CLINICAL TRIALS GROUP
    Anne Gershon; Fiscal Year: 2006
  5. VZV Receptors and Infective Mechanisms
    Anne Gershon; Fiscal Year: 2007
  6. VARICELLA ZOSTER--RECEPTORS AND INFECTIVE MECHANISMS
    Anne Gershon; Fiscal Year: 2000
  7. TRAINING IN PEDIATRIC INFECTIOUS DISEASE
    Anne Gershon; Fiscal Year: 2007
  8. Chronic Kidney Disease in Children Study (C-Kid)
    Susan Furth; Fiscal Year: 2007
  9. Patient Oriented Research in Pediatric Kidney Disease
    Susan Furth; Fiscal Year: 2007
  10. Assessing Functional Outcomes in Adolescent with ESRD
    Susan Furth; Fiscal Year: 2002

Detail Information

Publications199 found, 100 shown here

  1. doi Laboratory diagnosis and characteristics of breakthrough varicella in children
    Sheila Weinmann
    Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon 97227, USA
    J Infect Dis 197:S132-8. 2008
    ..The value of highly elevated IgG titers needs further evaluation. Larger studies are needed to confirm these results...
  2. ncbi Parental attitudes toward varicella vaccination. The Puget Sound Pediatric Research Network
    J A Taylor
    Department of Pediatrics, University of Washington School of Medicine, Seattle 98103 8652, USA
    Arch Pediatr Adolesc Med 154:302-6. 2000
    ..To evaluate parental health beliefs regarding the varicella vaccine and to identify potential areas for interventions designed to increase immunization against varicella...
  3. ncbi The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination
    Hester de Melker
    Centre for Infectious Disease Epidemiology, National Institute of Public Health and the Environment, P O Box 1, 3720 BA Bilthoven, The Netherlands
    Vaccine 24:3946-52. 2006
    ..Insight into epidemiology of varicella zoster is needed for the assessment of the desirability of introduction of routine varicella zoster vaccination...
  4. ncbi The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody
    Jay M Lieberman
    Miller Children s Hospital, UCLA Center for Vaccine Research, Long Beach, CA 90806, USA
    Pediatr Infect Dis J 25:615-22. 2006
    ..An additional objective was to evaluate the persistence of antibodies 1 year postvaccination...
  5. doi The burden of varicella complications before the introduction of routine varicella vaccination in Germany
    Johannes G Liese
    Dr von Hauner Children s Hospital, Ludwig Maximilians University, Munich, Germany
    Pediatr Infect Dis J 27:119-24. 2008
    ..The true burden of varicella complications in Germany is not known. We investigated the incidence and pattern of varicella complications in children and adolescents using 3 independent surveillance sources...
  6. pmc Attitudes and practices regarding varicella vaccination among physicians in Minnesota: implications for public health and provider education
    K R Ehresmann
    Acute Disease Epidemiology Section, Minnesota Department of Health, Minneapolis 55414, USA
    Am J Public Health 90:1917-20. 2000
    ..This study sought to determine physicians' attitudes and practices regarding varicella vaccine...
  7. ncbi Aging, immunity, and the varicella-zoster virus
    Ann Arvin
    Stanford University School of Medicine, Stanford, Calif, USA
    N Engl J Med 352:2266-7. 2005
  8. ncbi Varicella vaccines and measles, mumps, rubella, and varicella vaccine
    Lucia Ferro Bricks
    Departamento de Pediatria, Faculdade de Medicina da Universidade de São Paulo USP, Sao Paulo, SP, Brazil
    J Pediatr (Rio J) 82:S101-8. 2006
    ..To present an up-to-date review of studies investigating the efficacy, adverse events and vaccination regimens of the varicella vaccine and the new presentation combined with the vaccine for measles, mumps and rubella...
  9. ncbi The effect of vaccination on the epidemiology of varicella zoster virus
    W J Edmunds
    Immunisation Division, Colindale, London NW9 5EQ, UK
    J Infect 44:211-9. 2002
    ..Meanwhile sensitive surveillance of both chickenpox and shingles is essential in countries that have implemented, or are about to implement, varicella vaccination...
  10. ncbi Instituting a routine varicella vaccination program in Canada: an economic evaluation
    Denis Getsios
    Caro Research, Montreal, Canada
    Pediatr Infect Dis J 21:542-7. 2002
    ..The evaluation of a program of vaccination of 12-month-old children, with and without a catch-up program for susceptible 12-year-olds, is presented here...
  11. pmc Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus
    Yasuyuki Gomi
    Kanonji Institute, The Research Foundation for Microbial Diseases of Osaka University, Kanonji, Kagawa, Japan
    J Virol 76:11447-59. 2002
    ..Furthermore, the Oka vaccine virus was completely distinguishable from P-Oka and 54 clinical isolates by seven restriction-enzyme fragment length polymorphisms that detected differences in the DNA sequence...
  12. ncbi An elementary school outbreak of varicella attributed to vaccine failure: policy implications
    Brian R Lee
    Immunization, Tuberculosis, and International Health Section, Infectious Disease Epidemiology, Prevention, and Control Division, Minnesota Department of Health, Minneapolis 55414, USA
    J Infect Dis 190:477-83. 2004
    ....
  13. ncbi Hospitalizations for varicella in the United States, 1988 to 1999
    Karin Galil
    Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 21:931-5. 2002
    ..Varicella epidemiology is changing with increasing use of the varicella vaccine...
  14. ncbi Complications of varicella requiring hospitalisation before and after the introduction of varicella vaccine in a children's hospital in Taiwan
    Yu Yu Chuang
    Division of Paediatric Infectious Diseases, Chang Gung Children s Hospital, 5 Fu Shin Street, Kweishan, Taoyuan, Taiwan
    Eur J Pediatr 162:112-3. 2003
  15. ncbi Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination
    Christian R Frey
    Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA, and Faculty of Biosciences, University of Witten Herdecke, Witten, Germany
    J Infect Dis 188:40-52. 2003
    ..Varicella vaccination of 3 VZV-immune subjects was associated with increases in IE62 peptide-specific CD8(+) T cells, a finding indicating that in vivo re-exposure boosts memory immunity to this important viral protein...
  16. ncbi Prevention strategies: experience of varicella vaccination programmes
    David Patrick
    University of British Columbia, Centre for Disease Control, Vancouver, BC, Canada
    Herpes 14:48-51. 2007
    ..Ongoing surveillance for the reactivation of herpes zoster and safety programmes are also highlighted as key recommendations...
  17. doi The changing epidemiology of varicella incidence after implementation of the one-dose varicella vaccination policy
    Ie Bin Lian
    Graduate Institute of Statistics and Information Science, National Changhua University of Education, Changhua 50058, Taiwan
    Vaccine 29:1448-54. 2011
    ..The current study provides important implications for the current vaccination policy...
  18. pmc Complete DNA sequences of two oka strain varicella-zoster virus genomes
    Sueli L Tillieux
    Viral Vaccines Research and Development, GlaxoSmithKline Biologicals, Rue de l Institut, 89 P31 005, B 1330 Rixensart, Belgium
    J Virol 82:11023-44. 2008
    ....
  19. pmc Varicella: epidemiological aspects and vaccination coverage in the Veneto Region
    Vincenzo Baldo
    Department of Environmental Medicine and Public Health, Institute of Hygiene, University of Padua, Padua, Italy
    BMC Infect Dis 9:150. 2009
    ..To evaluate parameters at the start of the programme, we conducted a study to describe the epidemiology of varicella infection and coverage rates for varicella vaccine in the Veneto Region (North-East Italy)...
  20. ncbi Varicella outbreaks after vaccine licensure: should they make you chicken?
    U Buchholz
    Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pediatrics 104:561-3. 1999
    ..Vaccine effectiveness was within the range predicted by the literature. Vaccination led to a lower attack rate in the highly vaccinated CCC and appeared to protect from severe disease...
  21. ncbi Growth, morbidity and mortality after chickenpox infection in young children in Guinea-Bissau
    Anja Poulsen
    Projecto de Saude de Bandim, Guinea Bissau, Danish Epidemiology Science Centre, Statens Serum Institut, Copenhagen, Denmark
    J Infect 51:307-13. 2005
    ..To examine whether chickenpox in children below 2 years of age is associated with post-infection changes in growth, morbidity or mortality...
  22. doi Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP)
    Nicolas Goulleret
    Sanofi Pasteur MSD, Lyon, France
    Vaccine 28:5878-82. 2010
    ..The European VZVIP provides data on VZV clade distribution...
  23. doi An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients--Arkansas, 2006
    Philip L Gould
    Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 28:678-81. 2009
    ..In October 2006, the Arkansas Department of Health was notified of a varicella outbreak among students where some received a second dose during an outbreak-related vaccination campaign in February 2006...
  24. ncbi Use of National Health Insurance database to evaluate the impact of public varicella vaccination program on burden of varicella in Taiwan
    Hung Fu Tseng
    Institute of Medical Research, Chang Jung Christian University, 396, Sec l, Chang Jung Rd, Kway Jen, Tainan 711, Taiwan, ROC
    Vaccine 24:5341-8. 2006
    ..The reductions also occurred in every age group including infants and adults. This study showed significant evidence of vaccine impact with a marked decline in clinical cases in the short term...
  25. ncbi Analysis of the persistence of humoral and cellular immunity in children and adults immunized with varicella vaccine
    L Zerboni
    Department of Pediatrics, Stanford University School of Medicine, California 94305 5208, USA
    J Infect Dis 177:1701-4. 1998
    ..In summary, varicella immunization induced long-term humoral and cellular immunity, and initial differences between cell-mediated responses in children and adults diminished over time...
  26. doi Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases
    Paolo Bonanni
    Department of Public Health, University of Florence, Viale Morgagni 48, 50134 Florence, Italy
    Vaccine 26:5619-26. 2008
    ..Overall, our analysis confirmed the favourable clinical and economic impact of routine varicella vaccination with two doses of vaccine in Italy...
  27. ncbi Varicella vaccination in Australia
    K K Macartney
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases NCIRS, The Children s Hospital at Westmead, New South Wales, Australia
    J Paediatr Child Health 41:544-52. 2005
    ..The potential impact of varicella vaccination on the incidence of herpes zoster is also discussed...
  28. doi Molecular analysis of the Oka vaccine strain of varicella-zoster virus
    Koichi Yamanishi
    National Institute of Biomedical Innovation, Ibaraki, Osaka, Japan
    J Infect Dis 197:S45-8. 2008
    ....
  29. ncbi Disease burden and epidemiological characteristics of varicella in Taiwan from 2000 to 2005
    Yung Hsiu Lin
    Division of Infectious Diseases, Department of Pediatrics, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan
    J Microbiol Immunol Infect 42:5-12. 2009
    ..This study investigated the epidemiological characteristics and disease burden of varicella during the introduction of the varicella vaccine for mass vaccination in Taiwan...
  30. ncbi Postlicensure safety surveillance for varicella vaccine
    R P Wise
    Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, FDA CBER HFM 225, Rockville, MD 20852 1448, USA
    JAMA 284:1271-9. 2000
    ....
  31. pmc Varicella vaccination in Europe - taking the practical approach
    Paolo Bonanni
    Department of Public Health, University of Florence, Florence, Italy
    BMC Med 7:26. 2009
    ....
  32. ncbi Varicella
    Ulrich Heininger
    Division of Paediatric Infectious Diseases and Vaccinology, University Children s Hospital, Basel, Switzerland
    Lancet 368:1365-76. 2006
    ..Similar immunisation programmes have been adopted by some other countries, including Uruguay, Germany, Taiwan, Canada, and Australia, and are expected to be implemented more widely in future...
  33. ncbi Impact of varicella vaccination on health care utilization
    Fangjun Zhou
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 294:797-802. 2005
    ..However, national surveillance data are incomplete, and comprehensive data regarding outpatient as well as hospital utilization have not been reported...
  34. ncbi Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Mona Marin
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, GA 30333, USA
    MMWR Recomm Rep 56:1-40. 2007
    ..ACIP also approved criteria for evidence of immunity to varicella...
  35. ncbi Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine
    Timo Vesikari
    University of Tampere Medical School, Tampere, Finland
    Pediatr Infect Dis J 26:632-8. 2007
    ....
  36. ncbi A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax
    Keith S Reisinger
    Primary Physicians Research, Pittsburgh, PA 15241, USA
    Pediatrics 117:265-72. 2006
    ..A second dose of a varicella-containing vaccine may result in similar benefits...
  37. ncbi Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States
    Matthew M Davis
    Child Health Evaluation and Research Unit, Division of General Pediatrics, University of Michigan, Ann Arbor, Michigan 48109 0456, USA
    Pediatrics 114:786-92. 2004
    ..Previous studies have not found such effects. We studied trends in varicella-related hospitalization rates and associated charges before and after introduction of varicella vaccine...
  38. ncbi Universal varicella vaccination in the Veneto Region, Italy: launch of a programme targeting all children aged 14 months and susceptible adolescents
    V Baldo
    Department of Environmental Medicine and Public Health, Institute of Hygiene, University of Padua, Italy
    Euro Surveill 12:E071101.3. 2007
  39. ncbi Hospitalization rates for complicated and uncomplicated chickenpox in a poorly vaccined pediatric population
    F Bonsignori
    Department of Paediatrics, University of Florence, Anna Meyer Children s Hospital, Via Luca Giordano, 13, I 50132, Florence, Italy
    Infection 35:444-50. 2007
    ..A retrospective study was conducted to provide epidemiological data on hospitalization for complicated and uncomplicated chickenpox in a pediatric population...
  40. ncbi Is Europe ready to embrace a policy of universal varicella vaccination?
    J Ramet
    Universiteit Antwerpen, UZA and Paola Kinderziekenhuis ZNA, Antwerp, Belgium
    Int J Clin Pract 59:1326-33. 2005
    ..A universal varicella vaccination policy is an option that needs to be considered for Europe not only in medical terms but also because it would be socially and economically appropriate...
  41. doi Presumptive varicella vaccination is warranted in Greek adolescents lacking a history of disease or household exposure
    Alexandra Katsafadou
    Second Pediatric Clinic, Agia Sophia Childrens Hospital, Goudi, Athens, Greece
    Eur J Pediatr 168:23-5. 2009
    ..In conclusion, based on our local epidemiologic data, presumptive varicella vaccination should be offered to all adolescents with the exception of the subgroup of adolescents with household exposure...
  42. ncbi [Impact of universal varicella vaccination in Germany: an epidemiological and economic analysis]
    M Knuf
    Kinderklinik und Kinderpoliklinik, Johannes Gutenberg Universitat, Langenbeckstrasse 1, 55101 Mainz
    Klin Padiatr 218:203-12. 2006
    ..From these findings it can be concluded that universal varicella vaccination is a strategy which should be encouraged, from a medical, epidemiological, but also economic viewpoint...
  43. ncbi Decline in mortality due to varicella after implementation of varicella vaccination in the United States
    Huong Q Nguyen
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 352:450-8. 2005
    ..Starting in 1999, active and passive surveillance data showed sharp decreases in varicella disease. We reviewed national death records to assess the effect of the vaccination program on mortality associated with varicella...
  44. ncbi Survey of the status of self-paid varicella vaccination among children one to six years of age in Taiwan
    Sui Ling Liao
    Department of Pediatrics, Chang Gung Children s Hospital and Chang Gung Memorial Hospital, Taoyuan, Taiwan
    J Microbiol Immunol Infect 40:112-5. 2007
    ..Prior to 2004, the mass immunization program in Taiwan did not include varicella vaccine; however, parents could have their children vaccinated by the self-payment option...
  45. ncbi Varicella vaccination of children in the United States: assessment after the first decade 1995-2005
    Charles Grose
    Virology Laboratory, Department of Pediatrics, University of Iowa College of Medicine, Iowa City, IA 52242, USA
    J Clin Virol 33:89-95; discussion 96-8. 2005
    ..In addition, data from varicella vaccination programs in Europe should provide further insight into the effectiveness of varicella vaccination in different geographic and ethnic populations...
  46. ncbi Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002
    Aisha O Jumaan
    Centers for Disease Control and Prevention, Atlanta, Georgia 30345, USA
    J Infect Dis 191:2002-7. 2005
    ..We assessed the impact that varicella vaccination has on the incidence of varicella and of HZ...
  47. ncbi Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children
    Markus Knuf
    Childrens Hospital, Johannes Gutenberg University Hospital, Mainz, Germany
    Pediatr Infect Dis J 25:12-8. 2006
    ....
  48. ncbi Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years
    Timo Vesikari
    University of Tampere Medical School, Tampere, Finland
    Pediatr Infect Dis J 26:153-8. 2007
    ..Given the overlap in MMR and varicella vaccination schedules, development of a combined vaccine appears logical and would facilitate the introduction of 2 doses of varicella vaccination in healthy children with no additional injections...
  49. ncbi Physician attitudes regarding breakthrough varicella disease and a potential second dose of varicella vaccine
    Matthew M Davis
    Child Health Evaluation and Research Unit, Division of General Pediatrics, University of Michigan, Ann Arbor, MI, USA
    Pediatrics 119:258-64. 2007
    ..We assessed physicians' attitudes about the 1-dose varicella vaccination program and whether physicians think a 2-dose recommendation is needed to reduce the risk of breakthrough disease...
  50. ncbi Varicella vaccination in Europe: are we ready for a universal childhood programme?
    Nitu Sengupta
    Centre for Child Health, Royal London Hospital, 38 New Road, Whitechapel, London, E1 2AX, UK
    Eur J Pediatr 167:47-55. 2008
    ..The SIEVE recommends the implementation of such a policy as soon as financially and practically possible...
  51. ncbi A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
    M N Oxman
    Shingles Prevention Study Mail code 111F 1, VA San Diego Healthcare System, 3350 La Jolla Village Dr, San Diego, CA 92161, USA
    N Engl J Med 352:2271-84. 2005
    ..We tested the hypothesis that vaccination against VZV would decrease the incidence, severity, or both of herpes zoster and postherpetic neuralgia among older adults...
  52. ncbi Importance of catch-up vaccination: experience from a varicella outbreak, Maine, 2002-2003
    Mona Marin
    Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pediatrics 115:900-5. 2005
    ..We investigated this outbreak to examine reasons for its occurrence, including vaccine failure...
  53. ncbi Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad)
    Barbara J Kuter
    Merck Research Laboratories, P 0 Box 4, West Point 19426, Pennsylvania, USA
    Hum Vaccin 2:205-14. 2006
    ..Inc, West Point, PA) was evaluated in five clinical trials. Use of ProQuad would result in fewer injections for children and would facilitate universal immunization against all four diseases...
  54. ncbi Varicella-related complications and hospitalisations in a tertiary pediatric medical center before vaccine introduction
    Maria Theodoridou
    First Department of Paediatrics, Aghia Sophia Children s Hospital, Thivon and Levadias Str, 11527, Athens, Greece
    Eur J Pediatr 165:273-4. 2006
  55. ncbi Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey
    Handan Alp
    Department of Pediatrics, Ataturk Universitesi, 25 240 Erzurum, Turkey
    Health Policy 72:119-24. 2005
    ..The results were presented in order to design a strategy for vaccination against varicella-zoster virus (VZV)...
  56. doi Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005
    Sandra S Chaves
    Centers for Disease Control and Prevention, Atlanta, Georgia 30332, USA
    J Infect Dis 197:S127-31. 2008
    ..Continued surveillance of the risk and characteristics of breakthrough disease will be needed, to monitor the effect of the new 2-dose vaccine recommendation for children...
  57. doi Risk of herpes zoster in adults immunized with varicella vaccine
    Sophie Hambleton
    Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York, USA
    J Infect Dis 197:S196-9. 2008
    ..00 case/1000 person-years. Overall, the incidence of HZ in this cohort, therefore, is similar to published data for the US population in the prevaccine era...
  58. ncbi Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV
    M Brisson
    Immunisation Division, PHLS Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
    J Med Virol 70:S31-7. 2003
    ....
  59. ncbi Outbreak of varicella at a day-care center despite vaccination
    Karin Galil
    Centers for Disease Control and Prevention, Atlanta, USA
    N Engl J Med 347:1909-15. 2002
    ..We investigated an outbreak of varicella in a population of children with a high proportion of vaccinees who were attending a day-care center in a small community in New Hampshire...
  60. ncbi Epidemiology of Varicella-Zoster Virus in England and Wales
    M Brisson
    Immunisation Division, PHLS Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5WQ, United Kingdom
    J Med Virol 70:S9-14. 2003
    ..3 days and 25 vs. 4 deaths per 100,000 case). These results provide base-line estimates should mass varicella vaccination be introduced in England and Wales...
  61. doi Changing varicella epidemiology in active surveillance sites--United States, 1995-2005
    Dalya Guris
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 197:S71-5. 2008
    ..Continued surveillance will be important to monitor the impact that the 2-dose vaccine policy in children has on varicella epidemiology...
  62. doi Epidemiology of varicella in Connecticut, 2001-2005
    Lynn E Sosa
    Epidemic Intelligence Service, Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 197:S90-3. 2008
    ..Continued surveillance is needed in order to monitor changing trends in varicella epidemiology...
  63. pmc Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality data
    H Rawson
    Guy's King's College, St. Thomas's Hospital School of Medicine and Dentistry, London, UK
    BMJ 323:1091-3. 2001
    ..More of those who died were born outside United Kingdom than expected (12% v 4%). CONCLUSIONS: Chickenpox is not a mild disease. Deaths in adults are increasing, both in number and proportion...
  64. ncbi Varicella disease after introduction of varicella vaccine in the United States, 1995-2000
    Jane F Seward
    Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, Mailstop E 62, Atlanta, GA 30333, USA
    JAMA 287:606-11. 2002
    ..Before licensure of varicella vaccine in 1995, varicella was a universal childhood disease in the United States, causing 4 million cases, 11,000 hospitalizations, and 100 deaths every year...
  65. ncbi Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany
    Peter Wutzler
    Institute for Antiviral Chemotherapy, Friedrich Schiller University of Jena, Winzerlaer Strasse 10, Germany
    Med Microbiol Immunol 191:89-96. 2002
    ..In summary, routine childhood varicella vaccination appears to be a highly efficient strategy to significantly reduce the sizeable burden of varicella and would lead to net savings from both the societal but also the payer perspective...
  66. pmc Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997-2005
    J Quian
    Pediatric Department, Republic University, Montevideo, Uruguay
    Arch Dis Child 93:845-50. 2008
    ..We assessed the impact of the Uruguayan varicella vaccination programme during 2005, 6 years after its introduction...
  67. ncbi Pediatric sentinel surveillance of vaccine-preventable diseases in Italy
    Marta Luisa Ciofi degli Atti
    Laboratorio di Epidemiologia e Biostatistica, Istituto Superiore di Sanita, Rome, Italy
    Pediatr Infect Dis J 21:763-8. 2002
    ..In January, 2000, a pediatric sentinel network was launched, with the aim of monitoring in a timely and accurate way the geographic and temporal trends of vaccine-preventable diseases...
  68. ncbi Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children
    Henry R Shinefield
    Kaiser Permanente Vaccine Study Group, Oakland, CA 94612, USA
    Pediatr Infect Dis J 21:555-61. 2002
    ....
  69. ncbi Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox
    M Brisson
    Immunisation Division, PHLS Communicable Disease Surveillance Centre, London, UK
    Vaccine 20:2500-7. 2002
    ..Mass varicella vaccination is expected to cause a major epidemic of herpes-zoster, affecting more than 50% of those aged 10-44 years at the introduction of vaccination...
  70. ncbi An outbreak of varicella despite vaccination
    Jorge W Quian
    N Engl J Med 348:1405-7; author reply 1405-7. 2003
  71. pmc Epidemiology of varicella zoster virus infection in Canada and the United Kingdom
    M Brisson
    PHLS CDSC, and City University, London
    Epidemiol Infect 127:305-14. 2001
    ..Finally, our results provide baseline estimates of varicella and zoster incidence and morbidity for VZV vaccine effectiveness and cost-effectiveness studies...
  72. ncbi Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data
    C Aebi
    Department of Pediatrics, University of Bern, CH 3010 Inselspital, 3010, Bern, Switzerland
    Vaccine 19:3097-103. 2001
    ..The peak at 7-10 years may represent a transient loss of detectable antibody by some individuals...
  73. ncbi Empirical data on the varicella situation in Germany for vaccination decisions
    S Wagenpfeil
    Institute for Medical Statistics and Epidemiology, Technical University of Munich, Germany
    Clin Microbiol Infect 10:425-30. 2004
    ..In addition, significant economic benefits can be expected, mainly because of the high level of indirect health costs in Germany...
  74. ncbi Use of a computerized database to study the effectiveness of an attenuated varicella vaccine
    Justen H Passwell
    Safra Children s Hospital, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel
    Pediatr Infect Dis J 23:221-6. 2004
    ..The varicella vaccine Varilrix (GlaxoSmithKline) was introduced in Israel in June 2000 as an optional vaccination for children...
  75. doi An economic analysis of the universal varicella vaccination program in the United States
    Fangjun Zhou
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, Georgia, USA
    J Infect Dis 197:S156-64. 2008
    ....
  76. doi Varicella vaccination coverage in Bavaria (Germany) after general vaccine recommendation in 2004
    Andrea Streng
    University Children s Hospital, Department of Paediatric Infectiology and Immunology, Julius Maximilians University of Wurzburg, Josef Schneider Str 2, 97080 Wurzburg, Germany
    Vaccine 28:5738-45. 2010
    ..Additional programmes targeting paediatricians' and parents' acceptance of varicella vaccination are needed to achieve the WHO-defined goal of at least 85% coverage...
  77. ncbi Reactions of pediatricians to the recommendation for universal varicella vaccination
    R D Newman
    Department of Pediatrics, University of Washington School of Medicine, Children s Hospital and Medical Center, Seattle, USA
    Arch Pediatr Adolesc Med 152:792-6. 1998
    ....
  78. ncbi Varicella immunization practices and the factors that influence them
    S J Schaffer
    Strong Children s Research Center, Department of Pediatrics, University of Rochester School of Medicine and Dentistry, NY, USA
    Arch Pediatr Adolesc Med 153:357-62. 1999
    ..To evaluate the varicella immunization practices of physicians in Rochester, NY, and to identify factors that predict whether physicians administer varicella vaccine to children...
  79. ncbi Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes
    L Salleras
    General Directorate of Public Health, Department of Health and Social Security, Autonomous Government of Catalonia, Spain
    Vaccine 19:183-8. 2000
    ..These results suggest that the best vaccination strategy in Catalonia would be to add a temporary vaccination programme of pre-adolescents at 12 years to routine vaccination at 15 months...
  80. doi Varicella vaccination in Australia and New Zealand
    Kristine K Macartney
    National Centre for Immunisation Research and Surveillance, The Children s Hospital at Westmead, Westmead, Australia
    J Infect Dis 197:S191-5. 2008
    ..The anticipated licensure of combination measles-mumps-rubella-varicella vaccines in both countries may lead to future schedule changes...
  81. ncbi The postmarketing safety profile of varicella vaccine
    R G Sharrar
    Worldwide Product Safety and Epidemiology, Merck Research Laboratories, BLB 30, PO Box 4, West Point, PA 19486, USA
    Vaccine 19:916-23. 2000
    ..Eleven patients were hospitalized with complications of breakthrough varicella infection...
  82. ncbi The effectiveness of the varicella vaccine in clinical practice
    M Vazquez
    Department of Pediatrics, Yale University School of Medicine, New Haven, Conn 06520 8064, USA
    N Engl J Med 344:955-60. 2001
    ..A live attenuated varicella vaccine was approved for use in the United States in March 1995 and is recommended for all susceptible persons 12 months of age or older...
  83. ncbi A new combination vaccine for measles, mumps, rubella and varicella
    Grazyna Zareba
    Department of Environmental Medicine, University of Rochester, School of Medicine and Dentistry, Rochester, New York 14642, USA
    Drugs Today (Barc) 42:321-9. 2006
    ..The ProQuad combination vaccine facilitates implementation of varicella vaccination into routine childhood immunization schedules and will help to protect children against these four potentially serious diseases...
  84. ncbi Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1
    Saro H Armenian
    Division of General Pediatrics, Childrens Hospital Los Angeles, University of Southern California, USA
    Pediatr Infect Dis J 25:368-70. 2006
    ..The vaccine was well-tolerated. Varicella-zoster virus-specific lymphocyte proliferative responses were detected in all subjects by 4 weeks and in 9 of 10 subjects 1 year after vaccination...
  85. ncbi [Varicella-zoster virus infections. 1: Chickenpox and shingles. Treatment and prevention]
    S W Wassilew
    Dermatologische Klinik, Klinikum Krefeld
    MMW Fortschr Med . 2006
  86. doi An outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patients
    Amanda L Adler
    Department of Pediatrics, University of Washington, Children s Hospital and Regional Medical Center, Seattle, Washington 98105, USA
    Infect Control Hosp Epidemiol 29:866-70. 2008
    ..We describe an outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patients in October 2004...
  87. ncbi Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines
    D I Cohen
    Department of Epidemiology and Preventive Medicine, Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel
    Infection 34:208-13. 2006
    ..This large-scale study provides up-to-date estimates of Varicella zoster virus (VZV) age-specific seroprevalence and characteristics of VZV transmission in a representative sample of the Israeli population...
  88. doi Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life
    Volker Schuster
    Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany
    Pediatr Infect Dis J 27:724-30. 2008
    ..This study (104389/NCT00127023) was undertaken to assess the immunogenicity and safety of a new refrigerator-stable tetravalent MMRV vaccine after 1 dose and after 2 doses administered during the second year of life...
  89. doi Varicella-zoster virus infections
    Anne A Gershon
    Columbia University College of Physicians and Surgeons, New York, NY, USA
    Pediatr Rev 29:5-10; quiz 11. 2008
  90. doi A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella
    Jose Ramet
    Department of Pediatrics, Universitair Ziekenhuis Antwerpen, Antwerp Belgium
    Int J Infect Dis 11:S49-55. 2007
    ..Varicella is often considered to be a benign disease of childhood. In fact, varicella is associated with serious complications and mortality even among healthy individuals...
  91. doi The safety profile of varicella vaccine: a 10-year review
    Susan A Galea
    Merck Research Laboratories, Clinical Risk Management and Safety Surveillance, North Wales, Pennsylvania 19454 1099, USA
    J Infect Dis 197:S165-9. 2008
    ..Disseminated Oka VZV was identified in 6 immunocompromised patients and 1 patient with Down syndrome. This review has shown that the vaccine is generally safe and well tolerated...
  92. doi Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005
    Sandra S Chaves
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 197:S170-7. 2008
    ..Ongoing safety surveillance and further studies may shed light on some of the hypothesized associations...
  93. ncbi Varicella-zoster-virus genotypes in East London: a prospective study in patients with herpes zoster
    N Sengupta
    Department of Virology, Centre for Infectious Diseases, Institute of Cell Molecular Sciences, Queen Mary School of Medicine and Dentistry, Barts, Whitechapel, London, E1 2AT, United Kingdom
    J Infect Dis 196:1014-20. 2007
    ..The data presented provide a baseline against which to evaluate changes in the molecular epidemiology of varicella-zoster virus and the effect of immunization with the Japanese Oka vaccine strain...
  94. doi Perspective on live varicella vaccine
    Anne A Gershon
    Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    J Infect Dis 197:S242-5. 2008
    ....
  95. doi Development of varicella vaccine
    Michiaki Takahashi
    Department of Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan
    J Infect Dis 197:S41-4. 2008
    ..3%] of 260 vs. 12 [17.1%] of 70, respectively). Because of the pathogenesis of VZV, the incidence of latency and of HZ is predicted to be lower among vaccine recipients than among individuals who have experienced varicella...
  96. ncbi Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany
    A Sauerbrei
    Institute of Virology and Antiviral Therapy, Friedrich Schiller University of Jena, Jena, Germany
    J Med Virol 79:1025-31. 2007
    ..As reasons, the spread of viruses, which may be imported originally by persons immigrating from warmer climates, or the recombination between wild-and vaccine-type viruses have to be considered...
  97. pmc Primary vaccine failure after 1 dose of varicella vaccine in healthy children
    David E Michalik
    Division of Pediatric Infectious Diseases, Columbia University Medical Center, New York, New York 10032, USA
    J Infect Dis 197:944-9. 2008
    ..A second dose of varicella vaccine is expected to increase seroconversion rates and vaccine effectiveness...
  98. ncbi Analysis of factors associated with varicella-zoster virus susceptibility among children 0-12 years old in Taiwan
    C K Chang
    Department of Sport Management and Sport Science Research Center, National Taiwan College of Physical Education, 16, Sec 1, Shuan Shih Road, Taichung 404, Taiwan, ROC
    Med Mal Infect 37:222-8. 2007
    ..The aim of this study was to explore the geographical difference of VZV antibody seroprevalence among children in private vaccination areas in Taiwan, controlling for potential factors relating to varicella susceptibility...
  99. ncbi A combination vaccine against measles, mumps, rubella and varicella
    Markus Knuf
    Pediatric University Hospital, Johannes Gutenberg University, Mainz, Germany
    Drugs Today (Barc) 44:279-92. 2008
    ..For other countries considering introducing these vaccines, the advantages for children, parents and healthcare providers of protecting against four diseases in a single vaccine should be noted...
  100. doi Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine
    Barbara Watson
    Immunization Program Division of Disease Control, Philadelphia Department of Public Health, Philadelphia, Pennsylvania 19146, USA
    J Infect Dis 197:S143-6. 2008
    ....
  101. ncbi Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus
    Mark L Quinlivan
    Skin Virus Laboratory, Institute of Cell and Molecular Medicine, London, United Kingdom
    J Infect Dis 190:793-6. 2004
    ..This finding suggests that, between the time of inoculation of the vaccine and development of rash, selection of single strains occurs. The results have general implications for the pathogenesis of varicella-zoster virus...

Research Grants102 found, 100 shown here

  1. VARICELLA ZOSTER VIRUS
    Anne Gershon; Fiscal Year: 2002
    ..They will investigate gene expression during putative latency, including the comparative virulence of wild type and vaccine type VZV. ..
  2. BEHAVIORAL INTERVENTION FOR HERPES ZOSTER RISK IN AGING
    Michael Irwin; Fiscal Year: 2003
    ....
  3. Molecular Epidemiology of Fatal Prostate Cancer
    Sheila Weinmann; Fiscal Year: 2006
    ..The case-control study design will provide maximum statistical power for analysis of these relationships, particularly in the important African-American subgroup. ..
  4. PEDIATRICS AIDS CLINICAL TRIALS GROUP
    Anne Gershon; Fiscal Year: 2006
    ..We have competent, outstanding staff whose aim is not only to provide compassionate medical care to HIV-infected patients but also to perform meaningful and useful research on prevention and treatment of HIV infection. ..
  5. VZV Receptors and Infective Mechanisms
    Anne Gershon; Fiscal Year: 2007
    ..It may also make it possible to develop a safer and more efficacious vaccine. ..
  6. VARICELLA ZOSTER--RECEPTORS AND INFECTIVE MECHANISMS
    Anne Gershon; Fiscal Year: 2000
    ....
  7. TRAINING IN PEDIATRIC INFECTIOUS DISEASE
    Anne Gershon; Fiscal Year: 2007
    ..The renewal of this training grant will enable us to continue a training program that has so far been highly successful at this University during the past 5 years. ..
  8. Chronic Kidney Disease in Children Study (C-Kid)
    Susan Furth; Fiscal Year: 2007
    ..g. rapid progressors) and appropriately matched controls (e.g. non-progressors); and cross-cohort analyses utilizing parallel cohorts. ..
  9. Patient Oriented Research in Pediatric Kidney Disease
    Susan Furth; Fiscal Year: 2007
    ....
  10. Assessing Functional Outcomes in Adolescent with ESRD
    Susan Furth; Fiscal Year: 2002
    ..This experience will give Dr. Furth the tools she needs to develop into an independent clinical investigator in a nurturing academic environment. ..
  11. ASSESSING PATIENT OUTCOMES IN PEDIATRIC ESRD
    Susan Furth; Fiscal Year: 2003
    ..Furth the tools she needs to develop into an independent clinical investigator in a nurturing academic environment. ..
  12. Clinical Performance Measures & Outcomes in Adolescents
    Susan Furth; Fiscal Year: 2005
    ..abstract_text> ..
  13. Predictors of Cancer Screening in Diverse Practices
    Richard Zimmerman; Fiscal Year: 2004
    ..Without understanding the barriers to prevention from multiple vantage points, the rates of preventive services are unlikely to reach 2010 goals and needless cancer deaths will occur. ..
  14. VIRAL GASTROENTERITIS--BASIS OF PROTECTION AND VIRULENCE
    Ann Arvin; Fiscal Year: 2001
    ..In order to better understand the molecular and virologic basis of virulence and/or host tropism, we will identify relevant steps in the viral replication cycle in vivo that are restricted on the basis of host range. ..
  15. Protective Mechanisms Against Pandemic Respiratory Virus
    Ann Arvin; Fiscal Year: 2007
    ..These innovations will have broad relevance for for understanding human immunity against microbial pathogens of concern for biodefense. ..
  16. VARICELLA ZOSTER VIRUS--T CELL/SKIN TROPISMS AND IMMUNIT
    Ann Arvin; Fiscal Year: 2003
    ..These parallel investigations of VZV pathogenesis and immunity are directly linked by their practical relevance for improving live attenuated varicella vaccines. ..
  17. ONTOGENY OF MEASLES IMMUNITY IN INFANTS
    Ann Arvin; Fiscal Year: 2007
    ..Understanding the maturation of host responses to viral antigens during the first year of life has general relevance for vaccine strategies in infancy. ..
  18. Varicella-zoster Virus Tegument Proteins in Pathogenesis
    Ann Arvin; Fiscal Year: 2003
    ..A better understanding of the genetic mechanisms that are required for VZV virulence in skin, T cells and neural cells will guide the design of 'second generation' live attenuated varicella vaccines. ..
  19. Varicella-zoster Virus: Tegument Proteins in Pathogenesis
    Ann Arvin; Fiscal Year: 2009
    ..abstract_text> ..
  20. IMMUNITY & VIRAL REPLICATION IN CHILDREN WITH VARICELLA
    Ann Arvin; Fiscal Year: 1993
    ....
  21. Using MEPS Data to Inform Public-Plan Consumerism
    Matthew Davis; Fiscal Year: 2007
    ..Findings will have immediate relevance for implementation of the HOA projects and other consumerism efforts. ..
  22. ONTOGENY OF MEASLES IMMUNITY IN INFANTS
    Ann Arvin; Fiscal Year: 1999
  23. Sleep and Immune Mechanisms in Rheumatoid Arthritis
    Michael Irwin; Fiscal Year: 2009
    ..Results from this study will guide the development of interventions that target disordered sleep with potential effects on disability in RA. ..
  24. Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms
    Michael R Irwin; Fiscal Year: 2010
    ..This project will constitute the first, randomized controlled clinical trial of the effects of TCC on sleep outcomes in breast cancer survivors, and will advance psychobiological models of insomnia treatment mechanisms. ..
  25. T regulatory Cells in HSV Immunity and Immunopathology
    BARRY ROUSE; Fiscal Year: 2007
    ..Finally, a number of different strategies will be used to modulate the function of Treg cells in vivo to either increase immunity to HSV or reduce the damage resulting from HSV-induced immunopathology. ..
  26. ROCHESTER EPIDEMIOLOGY PROJECT
    Steven Jacobsen; Fiscal Year: 2004
    ..Although the basic data system has worked well, these aims will allow the applicants to extend the capabilities of this research infrastructure and insure its future usefulness. ..
  27. Alcoholism: Sleep and Cytokines in African Americans
    Michael Irwin; Fiscal Year: 2005
    ..g., cytokine antagonists) for sleep disturbance in alcoholism. ..
  28. MECHANISMS IN HERPETIC STROMAL KERATITIS
    BARRY ROUSE; Fiscal Year: 2002
    ..This approach may provide an alternative and/or adjunct means of managing the clinical expression of HSK in the natural host. ..
  29. Epidemiology of human metapneumovirus(hMPV) infection
    Marietta Vazquez; Fiscal Year: 2007
    ..abstract_text> ..
  30. Aging: Cytokine Mechanisms and Treatment of Insomnia
    Michael Irwin; Fiscal Year: 2009
    ..This study will advance psychobiological models of disordered sleep and the potential benefits of two readily exportable behavioral interventions for promoting improvements in sleep outcomes in the elderly. ..
  31. ROCHESTER EPIDEMIOLOGY PROJECT
    Steven Jacobsen; Fiscal Year: 2005
    ..abstract_text> ..
  32. KERATITIS TREATMENT WITH DRUG-CONTAINING IMMUNOLIPOSOMES
    BARRY ROUSE; Fiscal Year: 1991
    ..The results of our study may produce a vehicle for topical treatment of herpetic keratitis that is more effective than existing methods of treatment of stromal keratitis and may be effective when administered only once daily...
  33. OUTCOMES FOR IPV: PATIENT AND PROVIDER PERSPECTIVES
    Michael Rodriguez; Fiscal Year: 2003
    ..abstract_text> ..
  34. ANTIGENIC DETERMINANTS OF VARICELLA VIRUS
    Charles Grose; Fiscal Year: 2006
    ..These proposed VZV studies will provide further insight into the multiple functions of gE and the gE:gI complex. ..
  35. Mechanisms in Herpetic Keratitis
    BARRY ROUSE; Fiscal Year: 2006
    ..Investigations also focus on angiogenesis during clinical HSK and the relevance of therapies designed to inhibit neovascularization. ..